HEADER SIGNALING PROTEIN 08-MAR-18 6FX7
TITLE CRYSTAL STRUCTURE OF IN VITRO EVOLVED AF1521
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: [PROTEIN ADP-RIBOSYLGLUTAMATE] HYDROLASE AF_1521;
COMPND 3 CHAIN: A;
COMPND 4 EC: 3.2.2.-;
COMPND 5 ENGINEERED: YES;
COMPND 6 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: ARCHAEOGLOBUS FULGIDUS DSM 4304;
SOURCE 3 ORGANISM_TAXID: 224325;
SOURCE 4 GENE: AF_1521;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET19B
KEYWDS MACRO DOMAIN, ADP-RIBOSE BINDING, SIGNALING PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR T.KARLBERG,A.G.THORSELL,K.NOWAK,M.O.HOTTIGER,H.SCHULER
REVDAT 4 06-NOV-24 6FX7 1 REMARK
REVDAT 3 01-MAY-24 6FX7 1 JRNL
REVDAT 2 17-JAN-24 6FX7 1 REMARK
REVDAT 1 25-SEP-19 6FX7 0
JRNL AUTH K.NOWAK,F.ROSENTHAL,T.KARLBERG,M.BUTEPAGE,A.G.THORSELL,
JRNL AUTH 2 B.DREIER,J.GROSSMANN,J.SOBEK,R.IMHOF,B.LUSCHER,H.SCHULER,
JRNL AUTH 3 A.PLUCKTHUN,D.M.LESLIE PEDRIOLI,M.O.HOTTIGER
JRNL TITL ENGINEERING AF1521 IMPROVES ADP-RIBOSE BINDING AND
JRNL TITL 2 IDENTIFICATION OF ADP-RIBOSYLATED PROTEINS.
JRNL REF NAT COMMUN V. 11 5199 2020
JRNL REFN ESSN 2041-1723
JRNL PMID 33060572
JRNL DOI 10.1038/S41467-020-18981-W
REMARK 2
REMARK 2 RESOLUTION. 1.82 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.10.3
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.02
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2
REMARK 3 NUMBER OF REFLECTIONS : 17778
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.188
REMARK 3 R VALUE (WORKING SET) : 0.187
REMARK 3 FREE R VALUE : 0.212
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.780
REMARK 3 FREE R VALUE TEST SET COUNT : 849
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 9
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.93
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.11
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2764
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2140
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2627
REMARK 3 BIN R VALUE (WORKING SET) : 0.2134
REMARK 3 BIN FREE R VALUE : 0.2258
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.96
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 137
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1476
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 36
REMARK 3 SOLVENT ATOMS : 100
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 24.00
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.54
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -2.64960
REMARK 3 B22 (A**2) : -4.28520
REMARK 3 B33 (A**2) : 6.93470
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 5.22610
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.230
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.133
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.118
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.130
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.117
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 1573 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 2128 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 760 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : 281 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 1573 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 203 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 1870 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.02
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.54
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.78
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { A|* }
REMARK 3 ORIGIN FOR THE GROUP (A): -20.5563 -16.8081 6.8698
REMARK 3 T TENSOR
REMARK 3 T11: -0.0542 T22: -0.0620
REMARK 3 T33: -0.0660 T12: 0.0214
REMARK 3 T13: -0.0083 T23: -0.0447
REMARK 3 L TENSOR
REMARK 3 L11: 2.5334 L22: 1.2470
REMARK 3 L33: 1.6886 L12: -0.8507
REMARK 3 L13: 0.2295 L23: -0.0702
REMARK 3 S TENSOR
REMARK 3 S11: -0.1233 S12: -0.2603 S13: 0.1402
REMARK 3 S21: 0.0952 S22: 0.1157 S23: -0.1025
REMARK 3 S31: -0.0412 S32: 0.0405 S33: 0.0076
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6FX7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAR-18.
REMARK 100 THE DEPOSITION ID IS D_1200009026.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 08-FEB-18
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : DIAMOND
REMARK 200 BEAMLINE : I24
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.96861
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AUTOPROC 1.0.5
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17843
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820
REMARK 200 RESOLUTION RANGE LOW (A) : 70.020
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7
REMARK 200 DATA REDUNDANCY : 6.400
REMARK 200 R MERGE (I) : 0.18500
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85
REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0
REMARK 200 DATA REDUNDANCY IN SHELL : 5.40
REMARK 200 R MERGE FOR SHELL (I) : 2.52800
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.400
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 2BFQ
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 41.74
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 25 %W/V PEG3350, 0,2M SODIUM CHLORIDE,
REMARK 280 0.1 M BIS-TRIS, 2MM ADP-RIBOSE, PH 5.5, VAPOR DIFFUSION, SITTING
REMARK 280 DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 70.65600
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.76750
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 70.65600
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.76750
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 8480 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A -22
REMARK 465 GLY A -21
REMARK 465 HIS A -20
REMARK 465 HIS A -19
REMARK 465 HIS A -18
REMARK 465 HIS A -17
REMARK 465 HIS A -16
REMARK 465 HIS A -15
REMARK 465 HIS A -14
REMARK 465 HIS A -13
REMARK 465 HIS A -12
REMARK 465 HIS A -11
REMARK 465 SER A -10
REMARK 465 SER A -9
REMARK 465 GLY A -8
REMARK 465 HIS A -7
REMARK 465 ILE A -6
REMARK 465 ASP A -5
REMARK 465 ASP A -4
REMARK 465 ASP A -3
REMARK 465 ASP A -2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 MET A 86 -108.01 49.03
REMARK 500 SER A 141 -0.59 70.41
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue AR6 A 301
DBREF 6FX7 A 1 192 UNP O28751 Y1521_ARCFU 1 192
SEQADV 6FX7 MET A -22 UNP O28751 INITIATING METHIONINE
SEQADV 6FX7 GLY A -21 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -20 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -19 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -18 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -17 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -16 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -15 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -14 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -13 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -12 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -11 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 SER A -10 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 SER A -9 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 GLY A -8 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A -7 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 ILE A -6 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 ASP A -5 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 ASP A -4 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 ASP A -3 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 ASP A -2 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 LYS A -1 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 HIS A 0 UNP O28751 EXPRESSION TAG
SEQADV 6FX7 ARG A 15 UNP O28751 LYS 15 ENGINEERED MUTATION
SEQADV 6FX7 GLU A 35 UNP O28751 LYS 35 ENGINEERED MUTATION
SEQADV 6FX7 CYS A 74 UNP O28751 TYR 74 ENGINEERED MUTATION
SEQADV 6FX7 LEU A 97 UNP O28751 PHE 97 ENGINEERED MUTATION
SEQADV 6FX7 VAL A 103 UNP O28751 ILE 103 ENGINEERED MUTATION
SEQADV 6FX7 GLY A 105 UNP O28751 SER 105 ENGINEERED MUTATION
SEQADV 6FX7 GLY A 110 UNP O28751 GLU 110 ENGINEERED MUTATION
SEQADV 6FX7 ARG A 145 UNP O28751 TYR 145 ENGINEERED MUTATION
SEQADV 6FX7 ASP A 162 UNP O28751 ASN 162 ENGINEERED MUTATION
SEQRES 1 A 215 MET GLY HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS SER
SEQRES 2 A 215 SER GLY HIS ILE ASP ASP ASP ASP LYS HIS MET GLU VAL
SEQRES 3 A 215 LEU PHE GLU ALA LYS VAL GLY ASP ILE THR LEU ARG LEU
SEQRES 4 A 215 ALA GLN GLY ASP ILE THR GLN TYR PRO ALA LYS ALA ILE
SEQRES 5 A 215 VAL ASN ALA ALA ASN GLU ARG LEU GLU HIS GLY GLY GLY
SEQRES 6 A 215 VAL ALA TYR ALA ILE ALA LYS ALA CYS ALA GLY ASP ALA
SEQRES 7 A 215 GLY LEU TYR THR GLU ILE SER LYS LYS ALA MET ARG GLU
SEQRES 8 A 215 GLN PHE GLY ARG ASP CYS ILE ASP HIS GLY GLU VAL VAL
SEQRES 9 A 215 VAL THR PRO ALA MET ASN LEU GLU GLU ARG GLY ILE LYS
SEQRES 10 A 215 TYR VAL LEU HIS THR VAL GLY PRO VAL CYS GLY GLY MET
SEQRES 11 A 215 TRP SER GLY GLU LEU LYS GLU LYS LEU TYR LYS ALA PHE
SEQRES 12 A 215 LEU GLY PRO LEU GLU LYS ALA GLU GLU MET GLY VAL GLU
SEQRES 13 A 215 SER ILE ALA PHE PRO ALA VAL SER ALA GLY ILE ARG GLY
SEQRES 14 A 215 CYS ASP LEU GLU LYS VAL VAL GLU THR PHE LEU GLU ALA
SEQRES 15 A 215 VAL LYS ASP PHE LYS GLY SER ALA VAL LYS GLU VAL ALA
SEQRES 16 A 215 LEU VAL ILE TYR ASP ARG LYS SER ALA GLU VAL ALA LEU
SEQRES 17 A 215 LYS VAL PHE GLU ARG SER LEU
HET AR6 A 301 36
HETNAM AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-
HETNAM 2 AR6 OXOLAN-2-YL]METHYL [HYDROXY-[[(2R,3S,4R,5S)-3,4,5-
HETNAM 3 AR6 TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN
HETNAM 4 AR6 PHOSPHATE
HETSYN AR6 ADENOSINE-5-DIPHOSPHORIBOSE
FORMUL 2 AR6 C15 H23 N5 O14 P2
FORMUL 3 HOH *100(H2 O)
HELIX 1 AA1 ASP A 20 TYR A 24 5 5
HELIX 2 AA2 GLY A 41 GLY A 53 1 13
HELIX 3 AA3 ASP A 54 GLY A 71 1 18
HELIX 4 AA4 MET A 86 GLY A 92 5 7
HELIX 5 AA5 SER A 109 MET A 130 1 22
HELIX 6 AA6 ASP A 148 PHE A 163 1 16
HELIX 7 AA7 ASP A 177 LEU A 192 1 16
SHEET 1 AA1 7 GLU A 2 VAL A 9 0
SHEET 2 AA1 7 ILE A 12 GLN A 18 -1 O LEU A 14 N ALA A 7
SHEET 3 AA1 7 GLU A 170 ILE A 175 1 O LEU A 173 N ALA A 17
SHEET 4 AA1 7 SER A 134 PHE A 137 1 N PHE A 137 O VAL A 174
SHEET 5 AA1 7 ALA A 28 ALA A 33 1 N VAL A 30 O ALA A 136
SHEET 6 AA1 7 TYR A 95 VAL A 100 1 O THR A 99 N ALA A 33
SHEET 7 AA1 7 VAL A 81 PRO A 84 -1 N VAL A 81 O HIS A 98
SSBOND 1 CYS A 104 CYS A 147 1555 1555 2.02
SITE 1 AC1 24 ASP A 20 ILE A 21 ALA A 32 ALA A 33
SITE 2 AC1 24 ASN A 34 GLY A 41 GLY A 42 VAL A 43
SITE 3 AC1 24 ALA A 139 SER A 141 GLY A 143 ILE A 144
SITE 4 AC1 24 ARG A 145 TYR A 176 HOH A 402 HOH A 405
SITE 5 AC1 24 HOH A 411 HOH A 425 HOH A 426 HOH A 443
SITE 6 AC1 24 HOH A 450 HOH A 471 HOH A 479 HOH A 480
CRYST1 141.312 39.535 35.964 90.00 97.70 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.007077 0.000000 0.000957 0.00000
SCALE2 0.000000 0.025294 0.000000 0.00000
SCALE3 0.000000 0.000000 0.028059 0.00000